1. Metabolic Enzyme/Protease Immunology/Inflammation NF-κB
  2. Pyruvate Carboxylase (PC) NOD-like Receptor (NLR) NF-κB Interleukin Related
  3. Anemoside A3-methyl 6-aminohexanoate

Anemoside A3-methyl 6-aminohexanoate is an orally effective pyruvate carboxylase (PC) inhibitor with a Kd value of 10.1 μM against human PC. Anemoside A3-methyl 6-aminohexanoate exerts its function through the PC/NF-κB/NLRP3 inflammasome axis. Anemoside A3-methyl 6-aminohexanoate significantly alleviates symptoms of DSS (HY-116282C)-induced colitis in mice. Anemoside A3-methyl 6-aminohexanoate can be used in colitis-related research.

For research use only. We do not sell to patients.

Anemoside A3-methyl 6-aminohexanoate

Anemoside A3-methyl 6-aminohexanoate Chemical Structure

CAS No. : 2919975-48-5

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 Customer Validation

Top Publications Citing Use of Products

View All NOD-like Receptor (NLR) Isoform Specific Products:

View All NF-κB Isoform Specific Products:

View All Interleukin Related Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anemoside A3-methyl 6-aminohexanoate is an orally effective pyruvate carboxylase (PC) inhibitor with a Kd value of 10.1 μM against human PC. Anemoside A3-methyl 6-aminohexanoate exerts its function through the PC/NF-κB/NLRP3 inflammasome axis. Anemoside A3-methyl 6-aminohexanoate significantly alleviates symptoms of DSS (HY-116282C)-induced colitis in mice. Anemoside A3-methyl 6-aminohexanoate can be used in colitis-related research[1].

IC50 & Target[1]

NF-κB

 

IL-6

 

IL-1β

 

NLRP3

 

Cellular Effect
Cell Line Type Value Description References
THP-1 IC50
>= 80 μM
Compound: A3-6
Cytotoxicity against human THP-1 cells assessed as inhibition of cell viability incubated for 24 hrs by CCK8 assay
Cytotoxicity against human THP-1 cells assessed as inhibition of cell viability incubated for 24 hrs by CCK8 assay
[PMID: 38687956]
In Vitro

Anemoside A3-methyl 6-aminohexanoate (Compound A3-6) (0-10 μM; 0-25 h) potently inhibits PC enzyme activity in THP-1-derived macrophages with an IC50 of 0.058 μM, reduces LPS (HY-D1056)-induced proinflammatory cytokine secretion, and regulates pyruvate metabolism in a concentration-dependent manner[1].
Anemoside A3-methyl 6-aminohexanoate (1-10 μM; 0-13.5 h) dose-dependently inhibits NF-κB pathway activation and NLRP3 inflammasome activation in THP-1-derived macrophages[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: THP-1-derived macrophages
Concentration: 1, 10 μM (NF-κB pathway measurement); 1, 10 μM (NLRP3 inflammasome measurement)
Incubation Time: 1 h prior to 6 h LPS stimulation (NF-κB pathway measurement); 1 h prior to 12 h LPS + 0.5 h ATP stimulation (NLRP3 inflammasome measurement)
Result: Inhibited LPS-induced increases in p-p65 and p-IκBα protein levels in a concentration-dependent manner.
Significantly reduced LPS + ATP-induced NLRP3, Pro-IL-1β, P20, and IL-1β protein levels.

ELISA Assay[1]

Cell Line: Differentiated THP-1 cells treated LPS
Concentration: 0.1, 1, 10 μM
Incubation Time: 1 h prior to 24 h LPS stimulation
Result: Significantly decreased TNF-α
and IL-6 secretion in a concentration-dependent manner.
Parmacokinetics
Species Dose Route Tmax T1/2 Cmax AUC0-t MRT0-t CL Vd
Mice[1] 15 (Plasma) mg/kg p.o. 0.46 h 4.74 h 0.58 ng/mL 2.46 h·ng/g 5.13 h 15464.12 L/h/kg 357958.8 L/kg
Mice[1] 15 (Colon Tissue) mg/kg p.o. 1.92 h 4.65 h 7.12 ng/mL 30.18 h·ng/g 4.38 h 2525.07 L/h/kg 17324.05 L/kg
In Vivo

A3-6 (15-60 mg/kg; i.g.; daily; 8 days) alleviates dextran sulfate sodium (DSS, HY-116282C)-induced ulcerative colitis in male ICR mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ICR mice (male, 20-25 g, DSS-induced ulcerative colitis)[1]
Dosage: 15 mg/kg; 30 mg/kg; 60 mg/kg
Administration: i.g.; daily; 8 days
Result: Reduced DSS-induced body weight loss.
Dose-dependently decreased elevated disease activity index (DAI) scores.
Dose-dependently prevented colon shortening.
Reduced splenomegaly (lowered spleen index) in a dose-dependent manner.
Reduced colonic levels of the pro-inflammatory cytokine IL-6 in a concentration-dependent manner.
Decreased colon tissue pyruvate carboxylase (PC) activity at 60 mg/kg.
Increased colonic pyruvate levels at 60 mg/kg.
Inhibited DSS-induced IκBα degradation and P65 phosphorylation in mouse colon tissues.
Molecular Weight

878.14

Formula

C48H79NO13

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

C=C(C)[C@@H]1CC[C@]2(C(NCCCCCC(OC)=O)=O)CC[C@@]3(C)[C@]4(C)CC[C@@]5([H])[C@](C)(CO)[C@@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)CC[C@]5(C)[C@@]4([H])CC[C@]3([H])[C@]21[H]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, protect from light, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

Solvent & Solubility
In Vitro: 

DMSO : ≥ 100 mg/mL (113.88 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.1388 mL 5.6939 mL 11.3877 mL
5 mM 0.2278 mL 1.1388 mL 2.2775 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.1388 mL 5.6939 mL 11.3877 mL 28.4693 mL
5 mM 0.2278 mL 1.1388 mL 2.2775 mL 5.6939 mL
10 mM 0.1139 mL 0.5694 mL 1.1388 mL 2.8469 mL
15 mM 0.0759 mL 0.3796 mL 0.7592 mL 1.8980 mL
20 mM 0.0569 mL 0.2847 mL 0.5694 mL 1.4235 mL
25 mM 0.0456 mL 0.2278 mL 0.4555 mL 1.1388 mL
30 mM 0.0380 mL 0.1898 mL 0.3796 mL 0.9490 mL
40 mM 0.0285 mL 0.1423 mL 0.2847 mL 0.7117 mL
50 mM 0.0228 mL 0.1139 mL 0.2278 mL 0.5694 mL
60 mM 0.0190 mL 0.0949 mL 0.1898 mL 0.4745 mL
80 mM 0.0142 mL 0.0712 mL 0.1423 mL 0.3559 mL
100 mM 0.0114 mL 0.0569 mL 0.1139 mL 0.2847 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anemoside A3-methyl 6-aminohexanoate
Cat. No.:
HY-161627
Quantity:
MCE Japan Authorized Agent: